543331 Stock Overview
Manufactures and sells pigments and agrochemicals in India and internationally. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Meghmani Organics Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹93.65 |
52 Week High | ₹116.00 |
52 Week Low | ₹71.50 |
Beta | -0.079 |
11 Month Change | -14.36% |
3 Month Change | -1.52% |
1 Year Change | 29.66% |
33 Year Change | 10.76% |
5 Year Change | n/a |
Change since IPO | -0.90% |
Recent News & Updates
Recent updates
Shareholder Returns
543331 | IN Chemicals | IN Market | |
---|---|---|---|
7D | -3.1% | -4.2% | -3.4% |
1Y | 29.7% | 11.1% | 27.0% |
Return vs Industry: 543331 exceeded the Indian Chemicals industry which returned 11.1% over the past year.
Return vs Market: 543331 exceeded the Indian Market which returned 27% over the past year.
Price Volatility
543331 volatility | |
---|---|
543331 Average Weekly Movement | 6.4% |
Chemicals Industry Average Movement | 5.7% |
Market Average Movement | 6.2% |
10% most volatile stocks in IN Market | 9.2% |
10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 543331 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543331's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1986 | 1,720 | Ankit Patel | meghmani.com |
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. The company offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. It also offers agrochemical products comprising insecticides, which include cypermethrin, chlorpyriphos, alpha cypermethrin, permethrin, bifenthrin, lambda-cyhalothrin, deltamethrin, profenophos, acetamiprid, emamectin benzoate, and fipronil.
Meghmani Organics Limited Fundamentals Summary
543331 fundamental statistics | |
---|---|
Market cap | ₹23.78b |
Earnings (TTM) | -₹822.15m |
Revenue (TTM) | ₹17.20b |
1.4x
P/S Ratio-28.9x
P/E RatioIs 543331 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
543331 income statement (TTM) | |
---|---|
Revenue | ₹17.20b |
Cost of Revenue | ₹11.10b |
Gross Profit | ₹6.09b |
Other Expenses | ₹6.92b |
Earnings | -₹822.15m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -3.23 |
Gross Margin | 35.44% |
Net Profit Margin | -4.78% |
Debt/Equity Ratio | 53.2% |
How did 543331 perform over the long term?
See historical performance and comparison